8A
Wednesday, November 8, 1995
REVO Sunglasses
The Etc. Shop
928 Mass. Downtown
NATION/WORLD UNIVERSITY DAILY KANSAN
AN OPEN HOUSE THAT WILL OPEN DOORS
Wednesday November 16 5:00 p.m. 121 Stauffer-Flint The Kansan Advertising Staff will host an Open House for all prosecive applicants for the Spring 1995 Semester. All majors are encouraged to attend this informal, informative meeting to find out about opportunities available and take a behind-the-scenes look at you campus newspaper.
The University Daily Kansan, the #1 college newspaper in the nation, is now accepting applications for the Spring 1995 Advertising Staff. Positions include entry level sales, creative, photography and management. Positions for pay and credit available. Gain real world experience, credentials to land a great job, an opportunity to work in a cutting edge environment and a new set of friends that will last a lifetime.
THE UNIVERSITY DAILY KANSAN
The deadline for applications is November 17, 1994, at noon.
THE YACHT CLUB
Wednesday Margaritas $1.25 Well Drinks $1.75 Big Beers $1.50
Thursday Draws $0.75 Pitchers $2.50
Friday Busch, Busch Light, Keystone Light $1.50 5 House Shots $5.00 FREE TACO BAR (5-????)
Friday
842-9445
Saturday
Imports $2.00
House Shots $1.00
Cheeseburger/Curly Fries & either draw or Coke $2.75 Draws $0.75
Sunday
FDA considers new type of AIDS drug
Combining old and new drugs may help patients
The Associated Press
SILVER SPRING, Md. — The first of a long-anticipated class of new AIDS drugs should be approved for use in combination with older AIDS therapies because it can boost their effectiveness, scientists told the Food and Drug Administration yesterday.
A vote by the FDA advisory panel places a new drug called saquinavir in position to become the nation's first protease inhibitor, a new class of drugs that stalls the HIV virus by cripping an enzyme vital to the late stages of its reproduction.
All other AIDS drugs sold today are nucleoside analogs, which work on another part of the virus. If the FDA approves saquinavir, doctors would have the ability to attack HIV in two separate places for the first time, what FDA Commissioner David Kessler calls the "one-two punch."
But the panel voted unanimously that saquinavir should not be used alone, even for patients who are no longer helped by older AIDS drugs
The FDA is not obligated by advisory committee decisions but usually follows them.
because there is simply no proof that it would help them.
"My suspicion is we will see higher effects with higher doses," said panel chairman Fred Valentine of New York University Hospital.
The FDA knew there were serious questions about how well saquinavir would work, but rushed it to the panel in a record two months because the need for protease inhibitors is so great.
is so great.
Some questioned approving it without the final proof of how well it works, because insurance companies often won't pay for drugs without that data. And the activists blasted the FDA panel for not demanding better proof for AIDS drugs — and faster.
dard therapy, but not the same drop in the amount of virus in their blood that other AIDS drugs offer.
But patients who took saquinavir and AZT together showed more improvement, seeing a modest boost in their level of vital immune cells called CD4s and about an 85 percent drop in the amount of HIV in their blood. While Hoffman-La Roche said 25 percent of patients
Without that data, "this panel has become a toothless guardian of public health and a danger to people with AIDS," said Mark Herrington of the Treatment Action Group.
"My suspicion is we will see higher effects with higher doses." Fred Valentim New York University Hospital
Studies show patients who take saquinavir alone get about the same boost in their immune system as those who take AZT, the stan-
in one study had a 100 CD4 cell boost after four months of treatment, the FDA cautioned that most patients have just a 30 to 40 cell improvement.
Hoffman-La Roc h e acknowledges that only 4 percent of the drug is actually used by the body
and said it is developing a better formula. New studies indicate the dose, 1,800 milligrams a day, is too low to have a good effect. And there is some evidence that saquinavir might cause HIV to mutate in such a way that patients could never benefit from better protease inhibitors that are now being developed.
Court finds man insane in January shooting spree
Defendant thought killings would prove he was mind reader
The Associated Press
HILLSBOROUGH, N.C. — A former law student who went on a shooting rampage in Chapel Hill earlier this year, killing two men, was found not guilty yesterday by reason of insanity.
Lawyers for Wendell Williamson had argued during the two-week trial that their client was deluded when he fatally shot Kevin Reichardt and Ralph Walker and wounded two others in January.
The Orange County Superior Court jury, which received the case Monday, returned with the verdict shortly after resuming deliberations yesterday morning.
Williamson, 26, now will be sent to a mental hospital, and a hearing will be held within 50 days on whether he should be committed.
On Jan. 26, Williamson fired a semiautomatic rifle as he walked down a street near the University of North Carolina campus, continuing to shoot even after he was wounded by police. He was tackled finally by
Williamson, who had been treated at least twice at the University for paranoid schizophrenia, told police after he was arrested that he was telepathic and committed the acts to show the world he could read minds.
knew what he did was wrong. And he said five mental health experts called by the defense could not tell the jury Williamson's state of mind on the day of the shootings.
two bystanders, one of whom was wounded.
In his closing argument, District Attorney Carl Fox read extensively from Williamson's statement to police to show that the defendant
"In fact, there is no test they can give that shows he's insane," Fox said.
plate control of his mind in the weeks leading to the shooting.
"There's no motive here — no motive outside his delusion," Osborne said.
"This is not a case about malice." Osborne said. "This is not a case about evil-heartedness. This is a case about mental illness.
Osborne argued that Williamson's extensive planning for the shooting spree did not indicate he was sane. "A mentally ill person can plan, but
Defense attorney Kirk Osborne outlined three years of Williamson's deteriorating mental health and his belief that he was tepalistic. His delusion, Osborne said, took com-
"There's no motive here—no motive outside his delusion."
Kirk Osborne defense attorney
it's just a mentally ill plan."
tally ill plan.*
Williamson was charged with two counts of first-degree murder, two counts of shooting into a vehicle, one count of assault with a deadly weapon inflicting serious injury and 10 counts of assault with a deadly weapon
with intent to kill. He was found not guilty by reason of insanity on all charges.
Reichardt, 20, was a lacrosse player at the University; Walker, 42, worked at a restaurant.
Boy with optic tumor loses dogs
Missing beloved pets upsets Stilwell youth plagued by disease
The Associated Press
STILWELL — Having an inoperable brain tumor is tough enough for 7-year-old Ryan Perl. Losing his two beloved dogs has made it even tougher.
Perl's dogs, Shadow and Damon, escaped through a hole heavy winds created in their fence the night of Oct. 23.
"Shadow," he said of his tan-and-white Collie, "is so lovable. She was really easy to hug. I loved hugging her."
Perl's mother, Diane Perl, said losing his pets has been hard on him.
"After we learned about Ryan's problem, she'd stick to him as if she knew he needed protection. They were very close, and he's having a hard time right now."
Ryan Perl's problem is a tumor called an optic nerve glioma, which has wrapped itself around the boy's optic nerve and
squeezed the sight from his right eye. The tumor is in the center of his skull, surrounded by brain tissue.
"It's like living with a time bomb in your head," Diane佩 said.
"That's just like me," Ryan Perl told his mother. "I can't see with my right eve."
The tumor has not grown in two years and will not necessarily grow again. It could stop, and Ryan Perl could live to a ripe old age, his parents said.
But looking back, Diane Perl wondered how long the tumor had been present.
The family first became aware of a problem two years ago while watching a television show about vision problems.
His mother and father, Rick, were stunned. Ryan Perl's eye followed actions and dilated with the light, and he 'showed no signs of blindness.
"When he was learning to walk, and getting all the bumps and bruises that little boys get, I'd notice that the bumps were always on the right side of his face and wonder if there was a reason," she said.
After getting the diagnosis, the Perls decided to home school their children and change their lifestyle, eating only organically grown foods and removing all chemicals from their lives.
His parents are trying to protect him, but Ryan Perl fears being labeled as different.
This summer, he waited in a holding room with his father for two innings of a Royals baseball game while team officials sought clearance for him to bring his own organic juice into the stadium. He cannot drink soda.
"He just sat there sobbing, 'It's because of this thing in my head, isn't it?'" Rick Perl recalled. "It's because of the tumor that I'm different from other kids."
With all Ryan Perl has gone through, his father said that it was no wonder he would like his dogs back so much.
The family has posted filters in their search for Shadow and Damon, a black collie with a white band over his front shoulders.
Because the family will move to San Francisco in January, the dog hunt is even more important, the Perls said.